Latest Regenerative January 22, 2026 News

Subscribe

Cellistic Unveils New Induced Pluripotent Stem Cell Manufacturing Platforms for Cancer and Regenerative Therapies

The new platforms aim to streamline large-scale production of iPSC-derived cell therapies for new indications.

Aspect Biosystems Acquires Novo Nordisk’s Diabetes Stem Cell Therapy Tech

After stepping back from stem cell therapies last year, Novo is passing the torch on diabetes cell therapies to Aspect Biosystems, who will continue to commercialize the tech.

BlueRock Cell Therapeutics Receives FDA Orphan Drug for its Ocular Stem Cell Therapy, OpCT-001

OpCT-001 is an iPSC-derived cell therapy for retinitis pigmentosa, and it's now entering clinical testing following Orphan Drug status.
x
Subscribe
Subscribe

Stay updated on Regenerative Medicine

Subscribe